Enterprise Software Company Investment Opportunity in Hyderabad, India
Specialist Cloud ERP provider for Pharma and USFDA markets.
This transaction has concluded.
| Established | 10-20 year(s) |
| Employees | 10 - 50 |
| Legal Entity | Private Limited Company |
| Reported Sales | USD 80 - 90 thousand |
| Run Rate Sales | USD 90 thousand |
| EBITDA Margin | 30 - 40 % |
| Industries | Enterprise Software |
| Locations | Hyderabad |
| Local Time | 2:09 PM Asia / Kolkata |
| Listed By | Business Owner / Director |
| Status | Active |
Partial Stake Sale
USD
90 thousand
for
20.0%
stake
(Native Currency: INR 7,500,000)
Reason: Sales and Business Expansion.
Includes physical assets worth
USD
36 thousand
Documents
ROC-Verification.pdf
(59.3 KB)
Business Overview
- We have a USFDA approved product that is highly critical for India Pharma.
- Our clients are drug manufacturer and have 15 clients in India and abroad.
- We are expecting growth of 50%
- Founder has 12 years of industrial experience.
Products & Services Overview
ERP Solution for USFDA markets.
Facilities Overview
6000 Sqft office on lease.
Capitalization Overview
Not Disclosed
Recent Activity
-
Earlier than 15 daysCEO, Healthcare Consulting, Koto City, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysChairman And Managing Director, Real Estate Construction, Hyderabad, Corporate Investor / Buyer connected with the Business
Tags:
Enterprise Software Company Investment Opportunity in Hyderabad, India
·Invest in Enterprise Software Company in Hyderabad, India
·ERP Company Investment Opportunity in Hyderabad, India
·Enterprise Software Company Investment Opportunity
·Investment Opportunity in Hyderabad, India
·Invest in ERP Company in Hyderabad, India
·Invest in Enterprise Software Company
·ERP Company Investment Opportunity
·Invest in Hyderabad, India
·Invest in ERP Company
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
